Summary
- Current Price
- As of today, ICLR price is $163.57, down -1.18% on
- Current Price All-Time High
- ICLR price is currently -52.96% below its historical high of $347.72 set on
- Market Cap
- ICLR current market cap is $13B, down -8.44% year-over-year
- PE Ratio
- ICLR current PE ratio is 296.91
- Revenue
- ICLR current annual revenue is $8.25B, up +0.76% year-over-year
- Next Earnings
- The next earnings release for ICLR is on
Profile
| Metric | Value |
|---|---|
| Full Name | ICON Public Limited Company |
| Ticker | NASDAQ: ICLR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | Ireland |
| IPO | |
| Indexes | Not included |
| Website | iconplc.com |
| Employees | 39,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $163.57 | |
| Price, 1D Change | -1.18% | |
| Market Cap | $13B | |
| - | ||
| PE Ratio | 296.91 | |
| Beta | 1.37 | |
| Revenue | $8B | |
| Revenue, 1Y Change | +0.76% | |
| EPS | $2.90 | |
| EPS, 1Y Change | -67.37% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.90 | |
| EPS Estimate | N/A | $10.59 |
| EPS Est. Change | N/A | +264.54% |
| Revenue | $8.25B | |
| Revenue Estimate | N/A | $8.11B |
| Revenue Est. Change | N/A | -1.65% |
| Current Price | $163.57 | |
| Price Target | - | $186.50 |
| Price Tgt. Change | - | +14.02% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.01 | $8.90 | -36.48% | |
| $12.76 | $2.90 | -77.24% | |
| $10.59 | N/A | +264.54% | |
| $11.86 | N/A | +308.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.28B | $8.19B | -1.11% | |
| $8.03B | $8.25B | +2.75% | |
| $8.11B | N/A | -1.65% | |
| $8.41B | N/A | +1.91% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -1.72% | |
| Price, 3Y | -34.85% | |
| Market Cap, 1Y | -8.44% | |
| Market Cap, 3Y | -38.81% | |
| Revenue, 1Y | +0.76% | |
| Revenue, 3Y | +6.59% | |
| EPS, 1Y | -67.37% | |
| EPS, 3Y | -52.60% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $163.57 | |
| SMA 200 | $148.25 | |
| SMA 50 | $154.96 | |
| EMA 200 | $149.56 | |
| EMA 50 | $156.27 | |
| MACD | $3.77 | |
| Beta | 1.37 | |
| ATR | $8.55 | |
| 14-Day RSI | 48.61 | |
| 10-Day Volatility | 57.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $8.25B | |
| EPS | $2.90 | |
| Gross Profit | $1.79B | |
| Gross Margin | 21.72% | |
| Operating Income | $1.05B | |
| Operating Margin | 12.75% | |
| Net Income | $229.34M | |
| Net Margin | 2.78% | |
| EBITDA | $1.47B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.39 | |
| 1.10 | ||
| 1.10 | ||
| - | ||
| 7 | ||
| 2.00 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 296.91 | |
| 1.52 | ||
| 1.35 | ||
| 12.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $9.19B | |
| $647.30M | ||
| $16.27B | ||
| $3.50B | ||
| $7.08B | ||
| $3.20B | ||
| Total Debt | $3.56B | |
| $566.04M | ||
| $192.12M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.02B | ||
| $740.84M | ||
| $6.46B | ||
| $780.14M | ||
| $419.11M | ||
| $0.00 | ||
| $23.13M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $1.04B | ||
| -$187.53M | ||
| -$771.26M | ||
| Capex | $174.21M | |
| $861.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Citigroup | → | |
| Truist Securities | → | |
| Mizuho | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ICLR
FAQ
- What is the ticker symbol for ICON Public Limited Company?
- The ticker symbol for ICON Public Limited Company is NASDAQ:ICLR
- Does ICON Public Limited Company pay dividends?
- No, ICON Public Limited Company does not pay dividends
- What sector is ICON Public Limited Company in?
- ICON Public Limited Company is in the Healthcare sector
- What industry is ICON Public Limited Company in?
- ICON Public Limited Company is in the Diagnostics & Research industry
- What country is ICON Public Limited Company based in?
- ICON Public Limited Company is headquartered in Ireland
- When did ICON Public Limited Company go public?
- ICON Public Limited Company initial public offering (IPO) was on May 15, 1998
- Is ICON Public Limited Company in the S&P 500?
- No, ICON Public Limited Company is not included in the S&P 500 index
- Is ICON Public Limited Company in the NASDAQ 100?
- No, ICON Public Limited Company is not included in the NASDAQ 100 index
- Is ICON Public Limited Company in the Dow Jones?
- No, ICON Public Limited Company is not included in the Dow Jones index
- When was ICON Public Limited Company last earnings report?
- ICON Public Limited Company's most recent earnings report was on July 29, 2026
- When does ICON Public Limited Company report earnings?
- The next expected earnings date for ICON Public Limited Company is October 21, 2026
Data Sources & References
- ICLR Official Website www.iconplc.com
- ICLR Profile on Yahoo Finance finance.yahoo.com/quote/ICLR
- ICLR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iclr
